Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arinobu Tojo

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 6, 2022
[An overview of histiocytosis]Arinobu Tojo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Current status and future perspective in imatinib therapy against CML]Arinobu Tojo
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2007
[Physiopathology and treatment of chronic myeloid leukemia]Arinobu Tojo
Haematologica|August 2, 2008
Retraction. Heterogeneous promoter activity of the telomerase reverse transcriptase gene in individual acute myeloid leukemia cells defined by lentiviral reporter assayArinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Clinical use of tyrosine kinase inhibitors for treatment of myeloid leukemias]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 17, 2012
[Recent advances in cord blood stem cell transplantation]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Chronic myeloid leukemia]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Cytokine therapy for hematological malignancies]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Kinase inhibitors against hematological malignancies]Arinobu Tojo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Clinical sequencing in leukemia with the assistance of artificial intelligenceArinobu Tojo
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 6, 2022
[An overview of histiocytosis]Arinobu Tojo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2011
[Current status and future perspective in imatinib therapy against CML]Arinobu Tojo
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2007
[Physiopathology and treatment of chronic myeloid leukemia]Arinobu Tojo
Haematologica|August 2, 2008
Retraction. Heterogeneous promoter activity of the telomerase reverse transcriptase gene in individual acute myeloid leukemia cells defined by lentiviral reporter assayArinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Clinical use of tyrosine kinase inhibitors for treatment of myeloid leukemias]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 17, 2012
[Recent advances in cord blood stem cell transplantation]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Chronic myeloid leukemia]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Cytokine therapy for hematological malignancies]Arinobu Tojo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Kinase inhibitors against hematological malignancies]Arinobu Tojo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Clinical sequencing in leukemia with the assistance of artificial intelligenceArinobu Tojo
Pageof 32